Antidiabetic Effects of Yam (Dioscorea batatas) and Its Active Constituent, Allantoin, in a Rat Model of Streptozotocin-Induced Diabetes
Autor: | Mahbubur Rahman, Chong Sam Na, Gi Beum Kim, Jin Shang Kim, Choon Ho Song, Hyung Sub Kang, Shang Jin Kim, Hyeon Kyu Go |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2015 |
Předmět: |
Blood Glucose
Male Antioxidant antioxidant endocrine system diseases medicine.medical_treatment Antioxidants Rats Sprague-Dawley chemistry.chemical_compound Glucagon-Like Peptide 1 diabetic rat Allantoin Nutrition and Dietetics C-Peptide Dioscorea Malondialdehyde Glucagon-like peptide-1 Lipoproteins LDL Dioscorea batatas lcsh:Nutrition. Foods and food supply insulin hyperglycemia glucagon-like peptide-1 medicine.drug medicine.medical_specialty lcsh:TX341-641 Article Diabetes Mellitus Experimental Internal medicine Diabetes mellitus medicine Animals Hypoglycemic Agents Glycated Hemoglobin glucagon-likepeptide-1 Plant Extracts Superoxide Dismutase Insulin nutritional and metabolic diseases medicine.disease Streptozotocin Oxidative Stress Endocrinology chemistry Glycated hemoglobin Food Science Phytotherapy |
Zdroj: | Nutrients Nutrients, Vol 7, Iss 10, Pp 8532-8544 (2015) Nutrients(7): 10 Nutrients; Volume 7; Issue 10; Pages: 8532-8544 Volume 7 Issue 10 Pages 8532-8544 |
ISSN: | 2072-6643 |
Popis: | The objective of this study was to investigate the therapeutic efficacies of crude yam (Dioscorea batatas) powder (PY), water extract of yam (EY), and allantoin (the active constituent of yam) in streptozotocin (STZ)-induced diabetic rats with respect to glucose, insulin, glucagon-like peptide-1 (GLP-1), C-peptide, glycated hemoglobin (HbAlc), lipid metabolism, and oxidative stress. For this purpose, 50 rats were divided into five groups: normal control (NC), diabetic control (STZ), and STZ plus treatment groups (STZ + PY, STZ + EY, and STZ + allantoin). After treatment for one-month, there was a decrease in blood glucose: 385 ± 7 in STZ, 231 ± 3 in STZ + PY, 214 ± 11 in STZ + EY, and 243 ± 6 mg/dL in STZ + allantoin, respectively. There were significant statistical differences (p < 0.001) compared to STZ (100%): 60% in STZ + PY, 55% in STZ + EY, and 63% in STZ + allantoin. With groups in the same order, there were significant decreases (p < 0.001) in HbAlc (100% as 24.4 ± 0.6 ng/mL, 78%, 75%, and 77%), total cholesterol (100% as 122 ± 3 mg/dL, 70%, 67%, and 69%), and low-density lipoprotein (100% as 29 ± 1 mg/dL, 45%, 48%, and 38%). There were also significant increases (p < 0.001) in insulin (100% as 0.22 ± 0.00 ng/mL, 173%, 209%, and 177%), GLP-1 (100% as 18.4 ± 0.7 pmol/mL, 160%, 166%, and 162%), and C-peptide (100% as 2.56 ± 0.10 ng/mL, 129%, 132%, and 130%). The treatment effectively ameliorated antioxidant stress as shown by a significant decrease (p < 0.001) in malondialdehyde (100% as 7.25 ± 0.11 nmol/mL, 87%, 86%, and 85%) together with increases (p < 0.01) in superoxide dismutase (100% as 167 ± 6 IU/mL, 147%, 159%, and 145%) and reduced glutathione (100% as 167 ± 6 nmol/mL, 123%, 141%, and 140%). The results indicate that yam and allantoin have antidiabetic effects by modulating antioxidant activities, lipid profiles and by promoting the release of GLP-1, thereby improving the function of β-cells maintaining normal insulin and glucose levels. |
Databáze: | OpenAIRE |
Externí odkaz: |